Limited coverage drugs – febuxostat

Last updated on August 26, 2024

Generic name                          

febuxostat

Strength

80 mg

Form

tablet

Special Authority criteria

Approval period                            

For the reduction of serum uric acid levels in patients with gout who demonstrate immune-mediated hypersensitivity to allopurinol.

Indefinite

Practitioner exemptions

None

Special notes

  • Details regarding a patient’s immune-mediated hypersensitivity reaction to allopurinol is required.

Special Authority request form(s)